Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pelvic Exam Screening for Gynecologic Conditions

JAMA; 2017 Mar 7; Bibbins-Domingo, USPSTF, et al

The US Preventive Services Task Force (USPSTF) has issued a recommendation statement on screening for gynecologic conditions with pelvic examination. The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of performing screening pelvic exams in asymptomatic, nonpregnant adult women aged ≥18 years who are not at increased risk for any specific gynecologic condition.

The USPSTF statement concludes:

  • Current evidence is insufficient to assess the balance of benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult women. (I statement).
  • The statement does not apply to specific disorders for which the USPSTF already recommends screening (ie, screening for cervical cancer with a Papanicolaou [“Pap”] smear, screening for gonorrhea and chlamydia).

Citation:

Bibbins-Domingo; US Preventive Services Task Force. Screening for gynecologic conditions with pelvic examination. US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(9):947-953. doi:10.1001/jama.2017.0807.